Colgate Palmolive Co (CL) stock
CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3029% above fair value
$98.85−0.76 (-0.76%)
Close on Nov 18, 2026Market cap $78.58BP/E 38.8Yield 2.10%
Colgate Palmolive free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Colgate Palmolive's free cash flow for the twelve months ending Sep 30, 2026 was $3.79B, up 10.0% year over year. For fiscal 2025 it was $3.63B, up 2.5% from the year before. Over ten years it grew 4.9% a year on average. The highest annual figure on record is $3.63B in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.63B | +2.5% |
| FY2024 | Dec 31, 2024 | $3.55B | +16.6% |
| FY2023 | Dec 31, 2023 | $3.04B | +63.4% |
| FY2022 | Dec 31, 2022 | $1.86B | -32.6% |
| FY2021 | Dec 31, 2021 | $2.76B | -16.7% |
| FY2020 | Dec 31, 2020 | $3.31B | +18.3% |
| FY2019 | Dec 31, 2019 | $2.80B | +6.8% |
| FY2018 | Dec 31, 2018 | $2.62B | +4.8% |
| FY2017 | Dec 31, 2017 | $2.50B | -1.8% |
| FY2016 | Dec 31, 2016 | $2.55B | +12.8% |
| FY2015 | Dec 31, 2015 | $2.26B | -11.1% |
| FY2014 | Dec 31, 2014 | $2.54B | +0.3% |
| FY2013 | Dec 31, 2013 | $2.53B | -3.7% |
| FY2012 | Dec 31, 2012 | $2.63B | +11.5% |
| FY2011 | Dec 31, 2011 | $2.36B | -11.3% |
| FY2010 | Dec 31, 2010 | $2.66B | -1.5% |
| FY2009 | Dec 31, 2009 | $2.70B | +67.0% |
| FY2008 | Dec 31, 2008 | $1.62B | -3.1% |
| FY2007 | Dec 31, 2007 | $1.67B | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.04B | -6.2% |
| Q2 FY2026 | Jun 30, 2026 | $867.00M | +11.7% |
| Q1 FY2026 | Mar 31, 2026 | $609.00M | +27.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.28B | +17.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.11B | +7.1% |
| Q2 FY2025 | Jun 30, 2025 | $776.00M | -11.1% |
| Q1 FY2025 | Mar 31, 2025 | $476.00M | -14.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.09B | +15.5% |
| Q3 FY2024 | Sep 30, 2024 | $1.03B | +4.2% |
| Q2 FY2024 | Jun 30, 2024 | $873.00M | +62.3% |
| Q1 FY2024 | Mar 31, 2024 | $555.00M | -3.0% |
| Q4 FY2023 | Dec 31, 2023 | $939.00M | +107.7% |
| Q3 FY2023 | Sep 30, 2023 | $991.00M | +24.8% |
| Q2 FY2023 | Jun 30, 2023 | $538.00M | +53.7% |
| Q1 FY2023 | Mar 31, 2023 | $572.00M | +116.7% |
| Q4 FY2022 | Dec 31, 2022 | $452.00M | -50.5% |
| Q3 FY2022 | Sep 30, 2022 | $794.00M | -7.4% |
| Q2 FY2022 | Jun 30, 2022 | $350.00M | -29.6% |
| Q1 FY2022 | Mar 31, 2022 | $264.00M | -46.2% |
| Q4 FY2021 | Dec 31, 2021 | $913.00M | +13.7% |
| Q3 FY2021 | Sep 30, 2021 | $857.00M | -1.7% |
| Q2 FY2021 | Jun 30, 2021 | $497.00M | -47.6% |
| Q1 FY2021 | Mar 31, 2021 | $491.00M | -28.4% |
| Q4 FY2020 | Dec 31, 2020 | $803.00M | -6.7% |
| Q3 FY2020 | Sep 30, 2020 | $872.00M | +4.6% |
| Q2 FY2020 | Jun 30, 2020 | $949.00M | +66.8% |
| Q1 FY2020 | Mar 31, 2020 | $686.00M | +28.5% |
| Q4 FY2019 | Dec 31, 2019 | $861.00M | +15.3% |
| Q3 FY2019 | Sep 30, 2019 | $834.00M | +5.3% |
| Q2 FY2019 | Jun 30, 2019 | $569.00M | -2.4% |
| Q1 FY2019 | Mar 31, 2019 | $534.00M | +7.2% |
| Q4 FY2018 | Dec 31, 2018 | $747.00M | +27.0% |
| Q3 FY2018 | Sep 30, 2018 | $792.00M | -5.4% |
| Q2 FY2018 | Jun 30, 2018 | $583.00M | +15.2% |
| Q1 FY2018 | Mar 31, 2018 | $498.00M | -12.6% |
| Q4 FY2017 | Dec 31, 2017 | $588.00M | -5.6% |
| Q3 FY2017 | Sep 30, 2017 | $837.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $506.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $570.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $623.00M | – |
See a number that looks wrong?